Abstract
Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management.
Introduction
The auto-immune disease lupus erythematosus (LE) is associated with a broad range of cutaneous pathology. Cutaneous manifestations are frequently the presenting sign of LE, and in the case of certain cutaneous LE (CLE) sub-types, they can occur in the absence of systemic disease. CLE is two to three times more frequent than systemic lupus erythematosus (SLE) . Similar to proposed aetiologies for SLE, current theories discuss a multifactorial relationship leading to the development of cutaneous lupus, including genetic susceptibility, auto-immune induction and immune-system damage.

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

